Literature DB >> 17178222

Quinazoline and benzimidazole MCH-1R antagonists.

Rosa Arienzo1, Sue Cramp, Hazel J Dyke, Peter M Lockey, Dennis Norman, Alan G Roach, Phil Smith, Melanie Wong, Stephen P Wren.   

Abstract

We have modified the previously reported 2-aminoquinoline 1 to provide two novel series of MCH-1R antagonists. Representative compounds from the quinazoline and benzimidazole series have been shown to be potent and selective, with promising in vitro eADME profiles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178222     DOI: 10.1016/j.bmcl.2006.11.092

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.

Authors:  Matthew G LaPorte; Dimas José da Paz Lima; Feng Zhang; Malabika Sen; Jennifer R Grandis; Daniel Camarco; Yun Hua; Paul A Johnston; John S Lazo; Lynn O Resnick; Peter Wipf; Donna M Huryn
Journal:  Bioorg Med Chem Lett       Date:  2014-09-15       Impact factor: 2.823

2.  2-(5,6-Dihydro-benzimidazo[1,2-c]quinazolin-6-yl)-5-meth-oxy-phenol.

Authors:  Naser Eltaher Eltayeb; Siang Guan Teoh; Suchada Chantrapromma; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.